Evaristo Maiello - Researcher Profile

Publications

3 shown

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara , Mustafa Özgüroğlu , Yung‐Jue Bang +97 more

2018 The Lancet 1262 citations

Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma

Giuseppe Colucci , Francesco Giuliani , Vittorio Gebbia +7 more

Abstract BACKGROUND A prospective, randomized Phase III trial was performed to determine whether, compared with gemcitabine (GEM) alone, the addition of cisplatin (CDDP) to GEM ...

2002 Cancer 280 citations

Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study

Giuseppe Colucci , Roberto Labianca , Francesco Di Costanzo +17 more

Purpose Single-agent gemcitabine became standard first-line treatment for advanced pancreatic cancer after demonstration of superiority compared with fluorouracil. The Gruppo It...

2010 Journal of Clinical Oncology 299 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 1,841
Institution: Azienda Ospedaliero-Universitaria Careggi

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-3890-3435

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.